ZLAB Q1 2021 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+144.6% YoY

Gross Profit

-$191M-951.4% margin

Operating Income

-$227M-1129.6% margin

Net Income

-$233M-1158.6% margin

EPS (Diluted)

$-26.40

QoQ Revenue Growth

+33.2%

Cash Flow

Operating Cash Flow

-$170M

Free Cash Flow

-$171M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$122M

Stockholders' Equity

$1.0B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$8M	+144.6%
Gross Profit	-$191M	$6M	-3217.9%
Operating Income	-$227M	-$46M	-390.2%
Net Income	-$233M	-$48M	-385.4%

Revenue Segments

Zejula

$13M63%

Optune

$7M35%

Other

$367,0002%